Stefan F.
- Country
- Germany
- Department
- Kinderonkologisches Zentrum-Station 3, Haus 4, Ebene 2
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents
Data & Insights
Has run more than one trial at 255 of 355 partner sites.
Specializations
Pediatric Lymphomas
The investigator specializes in treating ALK-positive anaplastic large cell lymphoma and mature aggressive B-cell lymphomas in children and adolescents. Their research extends to innovative therapeutic approaches using targeted treatments for lymphoid malignancies.
- Standard risk ALCL management
- B-cell lymphoma therapeutics
- Pediatric lymphoma protocols
Pediatric Leukemias
Focused on advancing treatment for various forms of childhood leukemia, including acute lymphoblastic leukemia and myeloid leukemia in children with Down syndrome. The investigator has particular expertise in treating infant leukemia and relapsed cases.
- Infant ALL treatment
- Down syndrome-associated leukemia
- Relapsed ALL management
Solid Tumors
The investigator's expertise encompasses treatment of Ewing sarcoma and stage IV childhood renal tumors. Their work includes developing therapeutic strategies for both localized and metastatic disease presentations.
- Renal tumor protocols
- Ewing sarcoma treatment
- Metastatic disease management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.